Matinas BioPharma Holdings, Inc.

Ownership Transactions Reported by 13 Insiders

Symbol
MTNB on NYSE
Industry
Pharmaceutical Preparations
Location
1545 Route 206 South, Suite 302, Bedminster, NJ

There are no Buy or Sell transactions made by insiders since 11/8/2023

Matinas BioPharma Holdings, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Eric J. Ende Director Nov 1, 2023
Matthew Wikler Director Nov 1, 2023
Raphael J. Mannino Chief Scientific Officer Dec 14, 2021
Natasha Giordano Director Nov 1, 2023
James S. Scibetta Director Nov 1, 2023
Jerome D. Jabbour President and CEO, Director Dec 15, 2023
Kathryn Penkus Corzo Director Nov 1, 2023
Thomas Hoover Chief Business Officer Dec 15, 2023
James J. Ferguson III Chief Medical Officer Dec 15, 2023
Theresa Matkovits Chief Development Officer Dec 15, 2023
Hui Liu Chief Technology Officer Dec 15, 2023
Keith A. Kucinski Chief Financial Officer Dec 15, 2023
Herbert J. Conrad Director Nov 1, 2023

Recent Insider Transactions by Companies or Individuals for Matinas BioPharma Holdings, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.